Point-of-care diagnosis of hematological parameters using the HemoScreen device in a hematological-oncological patient population
Conditions
Interventions
Group 1: Qualification: Evaluation of the accuracy of complete blood count parameters measured using the point-of-care testing system (HemoScreen) from capillary blood in patients with hematological m
Sponsors
Universitätsklinikum Jena
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with hematological-oncological diseases undergoing chemotherapy
Exclusion criteria
Exclusion criteria: No possibility of capillary blood sampling from the fingertip
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Qualification: Measurements of complete blood count parameters using HemoScreen (capillary blood sample) and Sysmex XN (venous blood sample). Mobile laboratory: Implementation of the HemoScreen system for measurements in the patient's home environment. Prediction model: Development of an AI-supported prediction model. | — |
Secondary
| Measure | Time frame |
|---|---|
| Qualification: Comparison of blood values measured with the HemoScreen system with the reference values of the Sysmex XN. Determination of measurement accuracy (correlation coefficient, bias) according to predefined deviation limits. Mobile laboratory: Evaluation of point-of-care complete blood count measurements and patient questionnaires. Prediction model: Validation of the prediction model. | — |
Countries
Germany
Contacts
Public ContactMichael Kiehntopf
Universitätsklinikum Jena
Outcome results
None listed